Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II. - Wikidata - wikimedia - TriplyDB

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

http://www.wikidata.org/entity/Q35277460

about

DNA gyrase, topoisomerase IV, and the 4-quinolones Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis Coral-mucus-associated Vibrio integrons in the Great Barrier Reef: genomic hotspots for environmental adaptation Evaluating the genotoxicity of topoisomerase-targeted antibiotics Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa.Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzyme.Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential.A pyrimido[1,6-a]benzimidazole that enhances DNA cleavage mediated by eukaryotic topoisomerase II: a novel class of topoisomerase II-targeted drugs with cytotoxic potential Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones.Bacterial topoisomerase I as a target for discovery of antibacterial compounds.A "Double-Edged" Scaffold: Antitumor Power within the Antibacterial Quinolone.Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.New quinolones and gram-positive bacteria.

P2860

Q24643546-58D2F06C-06FC-45A5-9E25-CD99874369F9 Q24671373-FF19F537-403C-4985-AB9E-88F3853B0E41 Q28379245-925F2079-B2E0-4999-805A-39A55966C096 Q33804889-45662494-B858-40EC-B4EF-ADC78DF41C45 Q34095957-818172B0-01F3-4078-B7BB-10FD07E6B547 Q35115957-BB981BAA-4DCC-4170-96B1-08E8862555D6 Q35810950-B1D5AC8B-E0CA-40DC-A715-B95212D0A7A9 Q35897465-AF1C8171-3656-492B-82A5-1944575B4E2C Q35904133-10F64015-B990-46DE-AE9B-C58E8977D969 Q36758128-DCFE2DAA-CC67-4DD8-B967-279CD4176D19 Q37108422-1B4466C2-2084-489E-8315-2BA721F224CB Q37204002-719D0402-CAE9-4675-A269-DB3BCAB5EA6C Q39559188-7170D15F-AC9F-4096-A584-9B74A35981E1 Q39867252-11FBBD7C-732C-4E58-8291-CBB027485D4D Q40088128-291D5E1F-B388-4930-B681-0E612C93D675 Q40284884-41D95539-9268-46E1-9F08-0C1DB05D9EF1

P2860

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

http://www.wikidata.org/entity/Q35277460

description

1990 nî lūn-bûn

@nan

1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1990 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1990年の論文

@ja

1990年論文

@yue

1990年論文

@zh-hant

1990年論文

@zh-hk

1990年論文

@zh-mo

1990年論文

@zh-tw

1990年论文

@wuu

name

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

@ast

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

@en

type

label

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

@ast

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

@en

prefLabel

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

@ast

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

@en

P1433

Q35277460-B25E1D04-6716-44EE-8DC0-D6F9CEF6C4C0

P1476

Q35277460-850FDB12-7292-459D-BCFF-440B41B7F0C8

P2093

Q35277460-03E60864-475A-404A-ADAD-4D9B3EA2E9C8

Q35277460-2E4C3FDB-3106-4441-AEB8-17E134F35550

Q35277460-36046496-B49D-4F65-9CC1-6634D93AD820

Q35277460-EFC32755-1601-46EB-87F2-AF2FBC0617C9

P2860

Q35277460-05CC17E0-FAF7-4CF0-9329-85F98F9B19F7

Q35277460-1A413759-06FD-42F7-AB4B-E387DBAB86EB

Q35277460-26B057C1-F491-48A6-ADE9-386991398BE6

Q35277460-2F7632D0-10D1-4B74-9702-85CDA3E9CCD9

Q35277460-30C31C71-CA9F-4953-9978-6C3C38EDFA69

Q35277460-3C68D1C4-E43B-48D8-8025-6113E52E9F88

Q35277460-3E83A80B-C036-47A6-B64D-81EBBF437B3B

Q35277460-45CEC753-7B91-4C1E-A107-7F704D00042A

Q35277460-72852A34-7908-45EB-BC0E-0222E9D6E674

Q35277460-750F39F0-5A09-4545-8721-0DFC549F3AF4

P304

Q35277460-6278E8E4-9E03-4A9E-8044-1EB63F674528

P31

Q35277460-F0ED9697-5B9B-455E-8D57-16D5FEE21C62

P356

Q35277460-125FEADE-D7D2-4BE6-A731-78264DB8FCFF

P407

Q35277460-A3D548F3-AAE2-49F3-8915-72B8FD060B0F

P433

Q35277460-AEE6E2C9-DBEF-4770-974F-E8C2F58FD9CB

P478

Q35277460-4FE3E4BD-677A-4D25-9114-0E4579D333FC

P577

Q35277460-8B2CEC92-D2F7-4E73-A9E1-3516B497BB16

P5875

Q35277460-C8B28FA1-CC66-458D-8A1D-CC4FABE61F2A

P698

Q35277460-2810F0AE-3D83-453F-994B-7F13391CB9FB

P921

Q35277460-BA03868C-E2CE-45E7-9272-4968FB28A796

P932

Q35277460-BC2FB745-D35D-4028-91AA-539ABA9B9267

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

@en

P2093

Baron L

http://www.w3.org/2001/XMLSchema#string

Moreau NJ

http://www.w3.org/2001/XMLSchema#string

Robaux H

http://www.w3.org/2001/XMLSchema#string

Tabary X

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth

Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems

Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts

Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives

Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Association between early inhibition of DNA synthesis and the MICs and MBCs of carboxyquinolone antimicrobial agents for wild-type and mutant [gyrA nfxB(ompF) acrA] Escherichia coli K-12

Use of in vitro topoisomerase II assays for studying quinolone antibacterial agents

4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro.

Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.

DNA gyrase on the bacterial chromosome: possibility of two levels of action.

P304

1955-1960

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.34.10.1955

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P577

1990-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21193296

http://www.w3.org/2001/XMLSchema#string

P698

1963290

http://www.w3.org/2001/XMLSchema#string

P921

P932

171971

http://www.w3.org/2001/XMLSchema#string